Health & Fitness Hospitalized Covid patients 3x as likely to suffer cognitive issue
85% of hospitalized COVID patients have not recovered months later
Nearly 85 percent of hospitalized Covid patients report still feeling symptoms of the virus months later. More than 55 percent report developing a lung or heart condition related to the virus.Researchers from the University of Michigan analyzed 253 patients who were hospitalized towards the end of fall 2020 and winter 2021.
Hospitalizedpatients are more likely to suffer from cognitive issues months after recovery than patients who didn't require medical care, a new study suggests.
Researchers from Mount Sinai inexamined recovered Covid patients with no history of dementia or any other mental conditions.
They found that patients who were hospitalized were up to three times as likely to suffer a cognitive issue - including problems with attention and memory - after their bout with the virus.
Surprisingly, the team also found that people who suffered even mild-to-moderate cases of Covid see a decline in cognitive function - though at a much lower rate.
Chance of a severe breakthrough COVID case is less than one in 13,000
Severe breakthrough COVID-19 cases are incredibly rare, CDC data suggest. Fully vaccinated Americans have a less than one in 13,000 chance of breakthrough hospitalization or death.Americans who have received two doses of the Pfizer-BioNTech or Moderna vaccine or one shot of the Johnson & Johnson vaccine have a less than one in 13,000 chance of a severe breakthrough case, according to a DailyMail.com analysis of data from the Centers for Disease Control and Prevention (CDC).
'We found a relatively high frequency of cognitive impairment several months after patients contracted COVID-19,' researchers wrote in the study.
The research team, whose findings were published on Friday in, recruited 740 participants for the study, all of which had previously contracted Covid and had no history of dementia.
Number of cases has risen just 10% as rate of increase slows
On Sunday, the U.S. recorded 33,807 new cases of COVID-19 with a seven-day rolling average of 144,316, a 10% from the average four weeks ago as the growth rate has slowed.On Sunday, the U.S. recorded 33,807 new cases of COVID-19 with a seven-day rolling average of 144,316, according to data from Johns Hopkins University.
Of that group, 379 were outpatient cases, meaning they required little medical attention beyond a standard doctor's visit.
There were 165 participants whose case required an emergency room visit and 196 who required hospitalization due to the virus.
Each participant was given a variety of cognitive tests and screenings to detect any potential issues.
Outpatient participants were most likely to have memory encoding issues, 16 percent, or mental processing speed, 15 percent.
Memory encoding is the ability to process a memory, and processing speed is a person's ability to consume and examine information.
Those who required an emergency room visit were most likely to display issues in memory encoding, 26 percent, memory recall, 23 percent, and category fluency, 21 percent.
Video: What you need to know for World Menopause Day 2021 (Cover Video)
Memory recall is a person's ability to remember past events or facts that they know, and category fluency is a person's ability to remember words and subjects that are related to each other.
NIH awards $470 million to study the effects of long Covid
The NIH awarded $470 million to researchers who will study the long-term impacts of COVID-19. It goes to NYU Langone Medical Center, which will be the central hub for long Covid research.This grant will go to New York University (NYU) Langone Medical Center, which will act as the central hub for long Covid research and provide smaller grants to more than 100 scientists.
The worst off were those with the most severe Covid cases that required hospitalization.
More than three times as many hospitalized patients, 39 percent, displayed memory recall issues, as outpatient participants, 12 percent.
A large portion of hospitalized patients also were found to have category fluency issues, 35 percent, and memory encoding issues, 37 percent.
Across the board the hospitalized patients displayed more issues than others.
'The relative sparing of memory recognition in the context of impaired encoding and recall suggests an executive pattern,' researchers wrote.
'This pattern is consistent with early reports describing a dysexecutive syndrome after COVID-194 and has considerable implications for occupational, psychological, and functional outcomes.'
One worrying factor the researchers noted is that the participants in the study were relatively young, with a mean age of 49, too young to be displaying cognitive issues at this rate.
'It is well known that certain populations (eg, older adults) may be particularly susceptible to cognitive impairment after critical illness.
Anti-viral drug remdesivir reduces risk of hospitalization by 87%
After four weeks, 5.3% of the remdesivir group were hospitalized compared to 0.7% of the placebo group, decreasing the risk of hospitalization by 87%, new results from a clinical trial found.California-based Gilead Sciences Inc, the maker of the antiviral drug, published the results of its Phase III clinical trial on Wednesday.
'However, in the relatively young cohort in the present study, a substantial proportion exhibited cognitive dysfunction several months after recovering from COVID-19,' they wrote.
Unfortunately, young people suffering from cognitive issues, along with many other conditions, has become a well known and frequent symptom of a condition called 'long Covid'.
Experts are not exactly sure what causes the mysterious, yet common, condition where recovered Covid patients still feel symptoms of the virus months after recovery.
Dr Noah Greenspan, a New York based pulmonary care specialist who opened the first freestanding clinic dedicated to treating long Covid, told DailyMail.com that he often sees cognitive issues as a symptom of of the condition.
'Unfortunately, I see it a lot,' Greenspan wrote in an email.
'For those that are having significant cognitive issues, it has an incredibly detrimental impact on their lives.'
Hospitalised Covid patients told to use mouthwashes to ease infections .
Salisbury District Hospital is giving out four household brands of mouthwash on wards which are available on supermarket shelves for as little as £2 a bottle.Salisbury District Hospital is offering its patients one of three household brands, which are available on supermarket shelves from as little as £2 a bottle.